In the 1960s, thalidomide, a popular new drug is safe and effective, was open cause severe nerve damage and birth defects in babies, encouraging health workers to prohibit the use of the drug, and tighten the general restriction on new medicines and drugs. Twenty years later, after the recognition of the positive effects of thalidomide in the treatment of leprosy and its potential role in the treatment of certain types of cancer and HIV / AIDS cases, Celgene Corporation will have to deal with strict rules FDA, liability, public skepticism, and poor media image in order to secure approval of the drug. "Hide
by Daniel Diermeier, Jason Hermitage, Shail Tucker, Justin Heinze Source: Kellogg School Management 16 pages. Publication Date: 01 Oct 2006. Prod. #: KEL058-PDF-ENG
Related Case Solutions & Analyses:
Promoting Experimentation for Organizational Learning: The Mixed Effects of Inconsistency
Executive Decision Making at General Motors
Project Impact: The Affordable Hearing Aid Project
Digital Economy–The Need for Change
Creating a Corporate Advantage: The Case of the Tata Group
Four Strategies for the Age of Smart Services
Mahindra Aerospace: Looking Ahead
The Art of Work: Embracing Artistic Enquiry to Create Value
Rosewood Hotel and Resorts: Branding To Increase Customer Profitability and Lifetime Value
Narragansett Brewing Company
